Skip to main content
. Author manuscript; available in PMC: 2018 May 3.
Published in final edited form as: Clin Cancer Res. 2009 Feb 1;15(3):1019–1023. doi: 10.1158/1078-0432.CCR-08-1207

Table 2.

A. Allele distribution of TAP polymorphisms in women with and without high-grade cervical dysplasia

SNP Allele Control (n)* Case (n)* χ2 P
TAP1 I333V A 261 119 5.40 0.02
G 79 19
TAP1 D637D A 339 151 7.46 0.01
G 95 21
TAP2 I1379V G 350 149 2.68 0.10
A 70 19
TAP2 A665T A 335 133 0.27 0.60
G 38 37
TAP2 Q687STOP T 285 120 0.18 0.67
C 99 38
B. Allele distribution of TAP polymorphisms in high-risk HPV positive women with and without high-grade cervical dysplasia

TAP1 I333V A 138 96 4.75 0.03
G 50 18
TAP1 D637D A 185 126 8.99 0.00
G 67 20
TAP2 I1379V G 209 125 0.22 0.64
A 33 17
TAP2 A665T A 200 115 0.07 0.79
G 54 29
TAP2 Q687STOP T 172 103 0.08 0.77
C 48 31
*

Cases include women with CIN II and CIN III, controls include women with CIN I or no CIN.

P by Pearson's χ2 test.